However, some studies with a larger number of AML patients (n = 211, 331) have related MDR1 overexpression with a lower CR rate5,6, albeit using a heterogenous patient population, different treatment protocols and less sensitive techniques such as semi-quantitative RT-PCR or flowcytometry. Here, ABCB1 is linked to acute myeloid leukemia.